Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
QDEL QuidelOrtho
- 40.570
- -1.080-2.59%
Close Feb 14 16:00 ET
- 40.570
- 0.0000.00%
Post 20:01 ET
2.73BMarket Cap-1.35P/E (TTM)
42.240High38.770Low1.45MVolume42.050Open41.650Pre Close58.02MTurnover2.33%Turnover RatioLossP/E (Static)67.26MShares49.45052wk High0.91P/B2.52BFloat Cap29.73552wk Low--Dividend TTM62.06MShs Float306.724Historical High--Div YieldTTM8.33%Amplitude1.688Historical Low40.129Avg Price1Lot Size
About QuidelOrtho Company
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
Company Profile
SymbolQDEL
Company NameQuidelOrtho
Listing DateAug 7, 1981
Founded2022
CEOMr. Brian J. Blaser
MarketNASDAQ
Employees7100
Fiscal Year Ends12-29
Address9975 Summers Ridge Road
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-800-874-1517
Websitehttp://www.quidelortho.com
Company Executives
- Name
- Position
- Salary
- Brian J. Blaser
- Director, President and Chief Executive Officer
- --
- Louise Brandy
- Chief Information Officer
- --
- Joseph M. Busky
- Chief Financial Officer and Principal Accounting Officer
- 2.94M
- Philip McLellan
- Chief Operations Officer
- --
- Michelle A. Hodges
- Senior Vice President, General Counsel and Corporate Secretary
- --
- Dr. Werner Kroll, PhD
- Senior Vice President, Research and Development
- 2.03M
- Dr. Kenneth F. Buechler, PhD
- Chairman of the Board
- 411.50K
- Edward L. Michael
- Independent Director
- 326.94K
- Ann D. Rhoads
- Independent Director
- 110.83K
- Dr. Mary Lake Polan, M.D.,PhD
- Independent Director
- 105.00K
- John R. Chiminski
- Independent Director
- --
- Kenneth J. Widder, M.D.
- Independent Director
- 320.47K
- R. Scott Huennekens
- Independent Director
- --
- Dr. Matthew W. Strobeck, PhD
- Independent Director
- 280.00K
- Joseph D. Wilkins, Jr
- Independent Director
- 280.00K
- Evelyn S. Dilsaver
- Independent Director
- 286.95K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.